These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21849)

  • 1. Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.
    Giebink GS; Verhoef J; Peterson PK; Quie PG
    Infect Immun; 1977 Nov; 18(2):291-7. PubMed ID: 21849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.
    Matthay KK; Mentzer WC; Wara DW; Preisler HK; Lameris NB; Ammann AJ
    Infect Immun; 1981 Jan; 31(1):228-35. PubMed ID: 7216447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antibody concentration on opsonic requirements for phagocytosis in vitro of Streptococcus pneumoniae types 7 and 19.
    Chudwin DS; Wara DW; Lameris-Martin NB; Ammann AJ
    Proc Soc Exp Biol Med; 1983 Feb; 172(2):178-86. PubMed ID: 6402784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
    Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
    Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
    Giebink GS; Grebner JV; Kim Y; Quie PG
    Yale J Biol Med; 1978; 51(5):527-38. PubMed ID: 34937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
    Verhoef J; Peterson P; Kim Y; Sabath LD; Quie PG
    Immunology; 1977 Aug; 33(2):191-7. PubMed ID: 415969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.
    Tofte RW; Peterson PK; Schmeling D; Bracke J; Kim Y; Quie PG
    Infect Immun; 1980 Mar; 27(3):784-92. PubMed ID: 6103873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonic activity of normal human cerebrospinal fluid for selected bacterial species.
    Tofte RW; Peterson PK; Kim Y; Quie PG
    Infect Immun; 1979 Dec; 26(3):1093-8. PubMed ID: 43289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte phagocytosis and killing virulent and avirulent serotypes of Streptococcus pneumoniae.
    Braconier JH; Odeberg H
    J Lab Clin Med; 1982 Aug; 100(2):279-87. PubMed ID: 6284848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonization of group B streptococci in properdin deficient serum.
    Söderström C; Braconier JH; Christensen KK; Christensen P; Sjöholm AG
    Acta Pathol Microbiol Immunol Scand C; 1985 Dec; 93(6):251-6. PubMed ID: 3915179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte phagocytosis of Streptococcus pneumoniae in properdin-deficient serum.
    Braconier JH; Odeberg H; Sjöholm AG
    Infect Immun; 1983 Apr; 40(1):219-24. PubMed ID: 6403465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay.
    Gardner SE; Anderson DC; Webb BJ; Stitzel AE; Edwards MS; Spitzer RE; Baker CJ
    Infect Immun; 1982 Mar; 35(3):800-8. PubMed ID: 6802760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the alternate complement pathway in opsonization of several bacterial species.
    Forsgren A; Quie PG
    Infect Immun; 1974 Aug; 10(2):402-4. PubMed ID: 4152919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains.
    Meshulam T; Verbrugh HA; Verhoef J
    Eur J Clin Microbiol; 1982 Apr; 1(2):112-7. PubMed ID: 6816585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for quantitative variability of bacterial opsonic requirements.
    Guckian JC; Christensen WD; Fine DP
    Infect Immun; 1978 Mar; 19(3):822-6. PubMed ID: 25243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiencies in opsonic defense to pneumococci in the human newborn despite adequate levels of complement and specific IgG antibodies.
    Geelen SP; Fleer A; Bezemer AC; Gerards LJ; Rijkers GT; Verhoef J
    Pediatr Res; 1990 May; 27(5):514-8. PubMed ID: 2345679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-dependent alternate pathway of complement activation in opsonophagocytosis of Porphyromonas gingivalis.
    Cutler CW; Kalmar JR; Arnold RR
    Infect Immun; 1991 Jun; 59(6):2105-9. PubMed ID: 2037371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular trafficking and killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by opsonins.
    Gordon SB; Irving GR; Lawson RA; Lee ME; Read RC
    Infect Immun; 2000 Apr; 68(4):2286-93. PubMed ID: 10722631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum heat-labile opsonins in systemic lupus erythematosus.
    Jasin HE; Orozco JH; Ziff M
    J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle cell disease.
    Bjornson AB; Lobel JS; Harr KS
    J Infect Dis; 1985 Oct; 152(4):701-9. PubMed ID: 3930618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.